From on Medscape

Coverage from the

Transcatheter Cardiovascular Therapeutics (TCT) 2022

September 16 - 19, 2022; Boston, Massachusetts

September 16 - 19, 2022 Boston, Massachusetts
  • TCT 2022 Add PCSK9 Inhibitors to Statins at Primary PCI: EPIC-STEMI The powerful LDL-lowering agents aren't being used to their fullest potential, but giving them early to STEMI patients along with high-intensity statins would help amend that, researchers say.
  • TCT 2022 TAVR Now Used in Almost 50% of Younger Severe AS Patients TAVR rates in patients with aortic stenosis increased in all age groups since 2016, including those younger than 65, even though 2020 valve replacement guidelines recommend surgery in those patients.
  • TCT 2022 Prosthesis-Patient Mismatch Tied to Increased Mortality in TAVR Although it is known that prosthesis-patient mismatch causes worse outcomes in surgical aortic valve replacement, a new meta-analysis shows this is also the case in transcatheter procedures.

Conference News

© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.



Popular News from TCT 2021

Previous Coverage